Tsukuba, Japan

Miho Kawauchi


Average Co-Inventor Count = 3.9

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2003-2005

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Miho Kawauchi: Innovator in Pharmaceutical Chemistry

Introduction

Miho Kawauchi is a prominent inventor based in Tsukuba, Japan. She has made significant contributions to the field of pharmaceutical chemistry, particularly through her innovative work on benzimidazole derivatives and amido compounds. With a total of 3 patents, her inventions have the potential to impact medical treatments and drug development.

Latest Patents

Kawauchi's latest patents include novel benzimidazole derivatives that exhibit blood sugar level-depressing activity and PDE5-inhibiting activity. These compounds are useful as pharmaceutical preparations, showcasing her ability to create valuable medicinal products. Additionally, she has developed a process for producing 6-aminocarbonylmethyl-4H-2,3-dioxin-4-one compounds, which can be synthesized through a reaction involving a 6-halomethyl-4H-2,3-dioxin-4-one compound and a primary or secondary amine. This innovative method simplifies the production of important intermediates in pharmaceutical chemistry.

Career Highlights

Throughout her career, Miho Kawauchi has worked with notable companies such as Daicel Chemical Industries, Ltd. and Fujisawa Pharmaceutical Company, Ltd. Her experience in these organizations has allowed her to refine her skills and contribute to significant advancements in the field.

Collaborations

Kawauchi has collaborated with esteemed colleagues, including Noritsugu Yamasaki and Mitsuru Ohno. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Miho Kawauchi's contributions to pharmaceutical chemistry through her patents and collaborations highlight her role as a leading inventor in her field. Her work continues to pave the way for advancements in medical treatments and drug development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…